Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal

An appeal has been lodged for this appraisal, however it was rejected. Below are the papers related to this appeal.

For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.

This page was last updated: 24 November 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.